These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11021270)

  • 1. [Hormone therapy in heart failure: growth hormone and insulin-like growth factor I].
    Schnabel P; Mies F; Böhm M
    Z Kardiol; 1999 Jan; 88(1):1-9. PubMed ID: 11021270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
    Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone therapy in heart failure: where are we now?
    Demers C; McKelvie RS
    Congest Heart Fail; 2003; 9(2):84-90. PubMed ID: 12671339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone and insulin-like growth factor I in experimental heart failure.
    Ross J; Ryoke T
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():159-61. PubMed ID: 10990154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of growth hormone in chronic heart failure. Therapeutic implications.
    Volterrani M; Manelli F; Cicoira M; Lorusso R; Giustina A
    Drugs; 2000 Oct; 60(4):711-9. PubMed ID: 11085197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of terminal dilated cardiomyopathy with growth hormone].
    Dreifuss P
    Z Kardiol; 1998 Jun; 87(6):425-35. PubMed ID: 9691412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I: an attractive option for chronic heart failure?
    Donath MY; Zapf J
    Drugs Aging; 1999 Oct; 15(4):251-4. PubMed ID: 10582772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth hormone secretion in heart failure].
    Giustina A; Bonadonna S; Burattin A; Manelli F; Lorusso R; Volterrani M; Villa S; Dei Cas L; Agabiti Rosei E
    Minerva Endocrinol; 2003 Mar; 28(1):1-11. PubMed ID: 12621359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for growth factor treatment of muscle disease.
    Moxley RT
    Curr Opin Neurol; 1994 Oct; 7(5):427-34. PubMed ID: 7804464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure.
    Giustina A; Volterrani M; Manelli F; Desenzani P; Poiesi C; Lorusso R; Giordano A
    Am Heart J; 1999 Jun; 137(6):1035-43. PubMed ID: 10347328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies].
    Cittadini A; Durante Mangoni E; Palmieri EA; Casaburi C; Longobardi S; Di Rella F; Fazio S; Saccà L
    Cardiologia; 1998 Nov; 43(11):1185-92. PubMed ID: 9922584
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoglycemic effects of insulin-like growth factor-1 in experimental uremia: can concomitant growth hormone administration prevent this effect?
    Kovacs GT; Worgall S; Schwalbach P; Steichele T; Mehls O; Rosivall L
    Horm Res; 1999; 51(4):193-200. PubMed ID: 10474022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection.
    Lee PD; Pivarnik JM; Bukar JG; Muurahainen N; Berry PS; Skolnik PR; Nerad JL; Kudsk KA; Jackson L; Ellis KJ; Gesundheit N
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2968-75. PubMed ID: 8768860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of the somatopause and its treatment.
    Hoffman AR; Lieberman SA; Butterfield G; Thompson J; Hintz RL; Ceda GP; Marcus R
    Endocrine; 1997 Aug; 7(1):73-6. PubMed ID: 9449036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone resistance in chronic heart failure and its therapeutic implications.
    Cicoira M; Kalra PR; Anker SD
    J Card Fail; 2003 Jun; 9(3):219-26. PubMed ID: 12815572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined growth hormone (GH) and insulin-like growth factor-I (IGF-I) treatment is more effective than GH or IGF-I alone at enhancing recovery from neonatal malnutrition in rats.
    Zhao X; Donovan SM
    J Nutr; 1995 Nov; 125(11):2773-86. PubMed ID: 7472657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women.
    Thompson JL; Butterfield GE; Marcus R; Hintz RL; Van Loan M; Ghiron L; Hoffman AR
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1845-52. PubMed ID: 7539817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.